ClinOne, a provider of technologies for clinical trials, has unveiled the new Bring Your Own Device (BYOD) electronic patient-reported outcome (ePRO) intended to ensure zero data loss at clinical trial sites.

The solution is expected to help site sponsors by minimising the cost over hardware-derived ePRO solutions and the need to allocate provisioned devices.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Since patients can use their own devices, rather than third-party devices, they are set to experience little to virtually zero data loss, noted ClinOne.

This capability is said to ultimately benefit trial sites and sponsors because data loss could disqualify patients and lead to additional re-enrolment costs. It also improves trial retention rates, speeds up enrolment timeframe and increases patient compliance.

ClinOne CEO and co-founder Rob Bohacs said: “Utilising ClinOne’s ePRO solution for the appropriate trials can lead to significant cost-savings, particularly for those trials requiring routine diary entries, over several months or years.

“We are also planning wearable sensor integration in Q3 2019, which will allow correlation of data between ePRO and live sensor data – an industry first.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

According to the company, BYOD ePRO could decrease PRO charges by nearly 75% compared to the cost of paper and 65% or more over existing hardware-based providers.

The solution falls under the ClinTrialConnect suite of patient-facing technologies.

Patients will be able to access, complete, review and sign their diaries or questionnaires electronically by using DocuSign via the ClinTrialConnect patient portal.

Sites and patients will automatically get a completed version of the signed questionnaire.

Findings from 36 ovarian cancer trials showed that 41% of participants using the BYOD ePRO had avoidable missing data.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact